StockData
TransMedics Group, Inc. logo

TransMedics Group, Inc. (TMDX) shareholders

TMDXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3029% below fair value
$93.91+1.70 (+1.84%)

Close on Nov 17, 2026Market cap $3.26BP/E 24.4Yield 0.00%

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
100.0%
35M of 35M shares
Institutional holders
374
68 new, 106 sold out
Net institutional buying
-2M
In Q2 2026
Insider trades, 12 months
1 buys · 13 sales
Net sold $4.61M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Abigail P. Johnson
Joint filing with FMR LLC (15.00%)
5,058,39615.00%13G (passive) amendmentMar 31, 2025
BlackRock, Inc.4,955,26214.60%13G (passive) amendmentJun 30, 2025
Vanguard Portfolio Management1,949,4205.68%13G (passive)Mar 31, 2026
Vanguard Capital Management1,737,1375.06%13G (passive)Mar 31, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of TMDXValueChange% of portfolio
BlackRock, Inc.5,596,54916.14%$371.72M+303,2180.01%
FMR LLC5,133,32814.80%$340.96M+37,0850.01%
Vanguard Portfolio Management LLC1,933,9895.58%$128.46M+14,4540.01%
Vanguard Capital Management LLC1,497,6004.32%$99.47M+19,4480.00%
State Street Corp1,420,4214.10%$94.34M+100,9420.00%
Nomura Asset Management International Inc.910,4952.63%$60.48M+24,6540.09%
Geode Capital Management, LLC894,9132.58%$59.45M+55,7580.00%
Hood River Capital Management LLC751,1332.17%$49.89M+51,3630.36%
Dimensional Fund Advisors LP610,1071.76%$40.53M+93,4280.01%
Braidwell LP609,7151.76%$40.50M+280,3241.50%
Goldman Sachs Group Inc559,7711.61%$37.18M−306,5110.00%
Citadel Advisors LLC558,8241.61%$37.12M+497,2230.00%
Eventide Asset Management, LLC548,8741.58%$36.46M+500.49%
Wellington Management Group Llp515,9731.49%$34.27M+29,5000.01%
Emerald Advisers, LLC490,4911.41%$32.58M+147,7000.77%
UBS Group AG488,0581.41%$32.42M−92,7350.00%
Morgan Stanley405,1121.17%$26.91M−289,0380.00%
UBS Asset Management Americas Inc398,2501.15%$26.45M−541,2730.00%
Invesco Ltd.394,9791.14%$26.23M−642,9950.00%
Citigroup Inc386,0661.11%$25.64M+28,6850.01%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202637435M100.0%68 / 140123 / 1064M6M
Q1 202641637M100.0%67 / 149137 / 717M4M
Q4 202542937M100.0%90 / 156127 / 454M4M
Q3 202538838M100.0%75 / 153119 / 515M4M
Q2 202536837M100.0%104 / 116114 / 324M6M
Q1 202529939M100.0%52 / 12290 / 648M8M
Q4 202431539M100.0%74 / 13085 / 12511M9M
Q3 202437437M100.0%77 / 135123 / 4111M6M
Q2 202434035M99.9%107 / 97116 / 276M6M
Q1 202426235M100.0%51 / 9381 / 344M5M
Q4 202324837M100.0%49 / 8189 / 215M4M
Q3 202322136M100.0%34 / 9667 / 527M6M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

331 funds held TMDX in Q2 2026, 47% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of TMDXValue% of fundAs of
iShares Core S&P Small-Cap ETF2,082,5396.01%$138.32M0.12%Jun 30, 2026
Vanguard Total Stock Market Index Fund1,038,8903.00%$69.00M0.00%Jun 30, 2026
iShares Russell 2000 ETF891,4702.57%$59.21M0.07%Jun 30, 2026
Vanguard Small-Cap Index Fund752,1682.17%$49.96M0.03%Jun 30, 2026
Fidelity Small Cap Growth Fund726,1302.09%$55.56M0.63%Jul 31, 2026
Nomura Small Cap Core Fund617,3771.78%$41.49M0.75%May 29, 2026
Fidelity Advisor New Insights Fund614,3001.77%$40.80M0.14%Jun 30, 2026
VIP Contrafund Portfolio589,6001.70%$39.16M0.13%Jun 30, 2026
Eventide Gilead Fund460,6841.33%$30.60M0.89%Jun 30, 2026
Vanguard Small-Cap Growth Index Fund434,9561.25%$28.89M0.06%Jun 30, 2026
Vanguard Extended Market Index Fund397,5041.15%$26.40M0.03%Jun 30, 2026
VIP Mid Cap Portfolio383,7001.11%$25.49M0.27%Jun 30, 2026
Fidelity Small Cap Index Fund375,0961.08%$28.70M0.08%Jul 31, 2026
SMALLCAP World Fund Inc374,1771.08%$24.85M0.03%Jun 30, 2026
Fidelity Small Cap Growth K6 Fund370,0811.07%$28.31M0.62%Jul 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Waleed H. HassaneinPresident & CEO, Director666,1021.92%Jul 14, 2026
Fernando N. AraujoSee Remarks22,9690.07%Oct 30, 2026
Nicholas CorcoranSee remarks41,5580.12%Jul 14, 2026
Gerardo HernandezChief Financial Officer31,9350.09%Jul 14, 2026
Matthew S. ForsythSee Remarks15,4090.04%May 21, 2026
Anil P. RanganathSee remarks13,0910.04%Mar 4, 2026
Giovanni CecereChief Commercial Officer7,9750.02%Feb 20, 2026
Tamer I. KhayalChief Commercial Officer36,0420.10%Mar 5, 2025
James R. TobinDirector158,0680.46%Nov 12, 2026
David WeillDirector16,3920.05%Sep 14, 2026
Thomas J. GundersonDirector16,6420.05%Jun 17, 2026
Edward M. BasileDirector5,7880.02%May 22, 2026
Stephanie LovellDirector5,7880.02%May 22, 2026
Edwin KaniaDirector309,8740.89%May 22, 2026
Merilee RainesDirector6,9810.02%May 22, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
James R. Tobin
Director
Nov 9, 2026Sale−4,000$94.98$379.92K2,922
James R. Tobin
Director
Nov 9, 2026Sale−59$93.96$5.54K6,922
Fernando N. Araujo
See Remarks
Oct 28, 2026Award+22,969––22,969
David Weill
Director
Sep 11, 2026Buy+1,336$81.63$109.06K16,392
James R. Tobin
Director
Aug 17, 2026Gift−18,000––0
Waleed H. Hassanein
President & CEO, Director
Jul 10, 2026Award+49,669––171,093
Nicholas Corcoran
See remarks
Jul 10, 2026Award+11,727––41,558
Gerardo Hernandez
Chief Financial Officer
Jul 10, 2026Award+17,246––31,935
Thomas J. Gunderson
Director
Jun 15, 2026Sale−9,624$75.06$722.38K16,642
Thomas J. Gunderson
Director
Jun 15, 2026Option exercise+19,285$2.21$42.62K26,266
David Weill
Director
May 20, 2026Award+2,922––15,056
Edwin Kania
Director
May 20, 2026Award+2,922––263,732
Thomas J. Gunderson
Director
May 20, 2026Award+2,922––6,981
Edward M. Basile
Director
May 20, 2026Award+2,922––5,788
Stephanie Lovell
Director
May 20, 2026Award+2,922––5,788
James R. Tobin
Director
May 20, 2026Award+2,922––6,981
Merilee Raines
Director
May 20, 2026Award+2,922––6,981
Matthew S. Forsyth
See Remarks
May 19, 2026Award+15,409––15,409
Stephanie Lovell
Director
Mar 4, 2026Sale−1,193$149.62$178.50K2,866
David Weill
Director
Mar 4, 2026Option exercise+3,571$14.20$50.71K15,705
David Weill
Director
Mar 4, 2026Sale−3,571$146.82$524.29K12,134
Gerardo Hernandez
Chief Financial Officer
Mar 4, 2026Sale−5,912$147.21$870.31K14,689
Gerardo Hernandez
Chief Financial Officer
Mar 4, 2026Option exercise+5,912$69.84$412.89K20,601
Gerardo Hernandez
Chief Financial Officer
Mar 4, 2026Sale−1,324$147.21$194.91K14,689
Gerardo Hernandez
Chief Financial Officer
Mar 4, 2026Option exercise+1,324$77.12$102.11K16,013
Anil P. Ranganath
See remarks
Mar 2, 2026Sale−864$139.12$120.20K13,091
Nicholas Corcoran
See remarks
Mar 2, 2026Sale−2,966$139.12$412.63K29,831
Gerardo Hernandez
Chief Financial Officer
Mar 2, 2026Sale−375$139.12$52.17K14,689
Giovanni Cecere
Chief Commercial Officer
Feb 18, 2026Award+11,082––19,057
Nicholas Corcoran
See remarks
Jan 23, 2026Tax withholding−984$135.30$133.14K32,797
Gerardo Hernandez
Chief Financial Officer
Dec 4, 2025Sale−920$139.62$128.45K15,064
David Weill
Director
Dec 3, 2025Sale−5,000$138.64$693.20K12,134
David Weill
Director
Dec 3, 2025Option exercise+5,000$14.20$71.00K17,134
Anil P. Ranganath
See remarks
Nov 25, 2025Option exercise+3,000$93.88$281.64K16,955
Anil P. Ranganath
See remarks
Nov 25, 2025Sale−3,000$145.22$435.66K13,955
Waleed H. Hassanein
President & CEO, Director
Nov 17, 2025Buy+8,775$114.00$1.00M495,009
Edward M. Basile
Director
Oct 29, 2025Sale(10b5-1 plan)−4,142$130.45$540.32K2,866
Edward M. Basile
Director
Oct 29, 2025Option exercise+4,142$0.70$2.90K7,008
Waleed H. Hassanein
President & CEO, Director
Aug 7, 2025Buy+6,617$116.08$768.10K484,376
Waleed H. Hassanein
President & CEO, Director
Aug 7, 2025Buy+1,858$116.85$217.11K486,234
Waleed H. Hassanein
President & CEO, Director
Aug 6, 2025Buy+8,400$118.68$996.91K477,759
Edward M. Basile
Director
Aug 4, 2025Sale(10b5-1 plan)−4,143$125.51$519.99K2,866
Edward M. Basile
Director
Aug 4, 2025Option exercise+4,143$0.70$2.90K7,009
Anil P. Ranganath
See remarks
Jun 9, 2025Sale−686$139.80$95.90K13,955
Edward M. Basile
Director
May 27, 2025Sale(10b5-1 plan)−5,000$126.45$632.25K2,866
Edward M. Basile
Director
May 27, 2025Option exercise+5,000$0.70$3.50K7,866
David Weill
Director
May 23, 2025Sale−732$123.88$90.68K12,134
Edwin Kania
Director
May 22, 2025Award+2,134––260,810
Merilee Raines
Director
May 22, 2025Award+2,134––4,059
Edward M. Basile
Director
May 22, 2025Award+2,134––2,866
James R. Tobin
Director
May 22, 2025Award+2,134––4,059
David Weill
Director
May 22, 2025Award+2,134––12,866
Stephanie Lovell
Director
May 22, 2025Award+2,134––4,059
Thomas J. Gunderson
Director
May 22, 2025Award+2,134––4,059
Edward M. Basile
Director
May 9, 2025Sale(10b5-1 plan)−6,000$115.63$693.78K732
Edward M. Basile
Director
May 9, 2025Option exercise+6,000$0.70$4.20K6,732
Tamer I. Khayal
Chief Commercial Officer
Mar 3, 2025Sale−2,407$76.43$183.97K36,042
Waleed H. Hassanein
President & CEO, Director
Feb 25, 2025Award+59,781––121,424
Anil P. Ranganath
See remarks
Feb 24, 2025Award+5,634––14,641
Tamer I. Khayal
Chief Commercial Officer
Feb 24, 2025Award+17,606––38,449

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
26.64%
9M shares short
Days to cover
10.2
At 1M shares a day
Change since last report
+1.2%
From 9M shares
Short volume, 20 days
52.0%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of TransMedics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 291,098 shares on Sep 21, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
James R. Tobin
Director
Nov 9, 20264,059$385.47KNov 9, 2026Restricted Stock
Thomas J. Gunderson
Director
Jun 15, 20269,624$722.40KJun 15, 2026Stock Option Exercise
Gerardo Hernandez
Officer
Mar 4, 20267,236$1.07MMar 4, 2026Stock Option Exercise
Stephanie Lovell
Director
Mar 4, 20261,193$178.49KMar 4, 2026Restricted Stock
David Weill
Director
Mar 4, 20263,571$524.29KMar 4, 2026Stock Option Exercise
David Weill
Director
Dec 3, 20255,000$693.21KDec 3, 2025Stock Option Exercise
Anil P. Ranganath
Officer
Nov 25, 20253,000$435.67KNov 25, 2025Stock Option Exercise
Edward M. Basile
Director
Oct 29, 20254,142$540.32KOct 29, 2025Stock Option Exercise
Edward M. Basile
Director
Aug 4, 20254,143$519.99KAug 4, 2025Stock Option Exercise
Edward M. Basile
Director
May 27, 20255,000$632.25KMay 27, 2025Stock Option Exercise
David Weill
Director
May 23, 2025732$90.68KMay 23, 2025Restricted Stock
Edward M. Basile
Director
May 9, 20256,000$693.78KMay 9, 2025Stock Option Exercise
Stephen Gordon
Officer
Mar 4, 20255,942$389.85KMar 4, 2025RSU
Edward M. Basile
Director
Nov 5, 20246,750$564.01KNov 5, 2024Stock Option Exercise
Tamer I. Khayal
Officer
Nov 1, 20247,625$625.02KNov 1, 2024Stock Option Exercise

See a number that looks wrong?